BACE1 Levels Correlate with Phospho-Tau Levels in Human Cerebrospinal Fluid

Author(s): Soraia Barao, Lujia Zhou, Katarzyna Adamczuk, Tine Vanhoutvin, Fred van Leuven, David Demedts, Anne-Catherine Vijverman, Xavier Bossuyt, Rik Vandenberghe, Bart De Strooper

Journal Name: Current Alzheimer Research

Volume 10 , Issue 7 , 2013

Become EABM
Become Reviewer
Call for Editor


Previous studies have investigated the activity and protein levels of BACE1, the β-secretase, in the brain and cerebrospinal fluid (CSF) of Alzheimer’s disease (AD) patients, however, results remain contradictory. We present here a highly specific and sensitive BACE1 ELISA, which allows measuring accurately BACE1 levels in human samples. We find that BACE1 levels in CSF of AD patients and other neurological disorder (OND) patients are slightly increased when compared to those of a non-neurological disorder control group (NND). BACE1 levels in CSF were well correlated with total-tau and hyperphosphorylated tau levels in the CSF, suggesting that the recorded alterations in BACE1 levels correlate with cell death and neurodegeneration.

Keywords: Alzheimer’s disease, BACE1, biomarker, human CSF, neurodegeneration, sandwich ELISA.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Published on: 31 July, 2013
Page: [671 - 678]
Pages: 8
DOI: 10.2174/15672050113109990138
Price: $65

Article Metrics

PDF: 20